Exact Mass: 644.1240271999999
Exact Mass Matches: 644.1240271999999
Found 28 metabolites which its exact mass value is equals to given mass value 644.1240271999999,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
1-O-(E)-Caffeoyl-4,6-(S)-HHDP-beta-D-glucopyranose
1-O-(E)-Caffeoyl-4,6-(S)-HHDP-beta-D-glucopyranose
1-O-(E)-caffeoyl-4,6-(S)-hexahydroxydiphenyl-beta-D-glucopyranose
1-O-(E)-caffeoyl-4,6-(S)-hexahydroxydiphenyl-beta-D-glucopyranose
Luteolinidin-5-(2-O-alpha-D-glucopyranosyl-2-glucose)|Luteolinidin-5-<2-O-alpha-D-glucopyranosyl-2-glucose>
Luteolinidin-5-(2-O-alpha-D-glucopyranosyl-2-glucose)|Luteolinidin-5-<2-O-alpha-D-glucopyranosyl-2-glucose>
quercetin 3-O-(2-O-galloyl-beta-D-glucuronide 6-methyl ester)
quercetin 3-O-(2-O-galloyl-beta-D-glucuronide 6-methyl ester)
[8,8-bi-2H-1-benzopyran]-2,2-dione,7-(alpha-D-glucopyranosyloxy)-7-hydroxy-3-[(2-oxo-2H-1-benzopyran-7-yl)oxy]
[8,8-bi-2H-1-benzopyran]-2,2-dione,7-(alpha-D-glucopyranosyloxy)-7-hydroxy-3-[(2-oxo-2H-1-benzopyran-7-yl)oxy]
N-acetyl-8-O-(N-acetyl-a-neuraminyl)-neuraminic acid disodium salt
N-acetyl-8-O-(N-acetyl-a-neuraminyl)-neuraminic acid disodium salt
[(6R)-9-[(2R,3R,4R,5R)-4-hydroxy-5-[[hydroxy-[hydroxy-[[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methoxy]phosphoryl]oxyphosphoryl]oxymethyl]-3-phosphonooxyoxolan-2-yl]-1,2,3,6-tetrahydropurin-6-yl]azanium
[(6R)-9-[(2R,3R,4R,5R)-4-hydroxy-5-[[hydroxy-[hydroxy-[[(2R,3S,4R,5R)-3,4,5-trihydroxyoxolan-2-yl]methoxy]phosphoryl]oxyphosphoryl]oxymethyl]-3-phosphonooxyoxolan-2-yl]-1,2,3,6-tetrahydropurin-6-yl]azanium
2-Azaniumyl-5-[[3-[[2-[(4-azaniumyl-4-carboxylatobutanoyl)amino]-3-(carboxylatomethylamino)-3-oxopropyl]trisulfanyl]-1-(carboxylatomethylamino)-1-hydroxypropan-2-yl]amino]-5-oxopentanoate
2-Azaniumyl-5-[[3-[[2-[(4-azaniumyl-4-carboxylatobutanoyl)amino]-3-(carboxylatomethylamino)-3-oxopropyl]trisulfanyl]-1-(carboxylatomethylamino)-1-hydroxypropan-2-yl]amino]-5-oxopentanoate
C20H32N6O12S3-2 (644.1240271999999)
dAp-dAp
dAp-dAp
C20H26N10O11P2 (644.1257706000001)
A 5-phospho-(3->5)-dinucleotide composed from two dAMP residues.
Thymidine 5-monophosphate dimer
Thymidine 5-monophosphate dimer
A cyclobutadipyrimidine bis(deoxyribonucleotide) obtained by formal cyclodimerisation of thymidine 5-monophosphate.
alpha-D-Glcp-(1->3)-[L-alpha-D-Hepp-(1->7)]-L-alpha-D-Hepp-4P
alpha-D-Glcp-(1->3)-[L-alpha-D-Hepp-(1->7)]-L-alpha-D-Hepp-4P
6-(4,5-dihydroxy-2-{3,5,7-trihydroxy-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,4-dihydro-2H-1-benzopyran-2-yl}phenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
6-(4,5-dihydroxy-2-{3,5,7-trihydroxy-6-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,4-dihydro-2H-1-benzopyran-2-yl}phenoxy)-3,4,5-trihydroxyoxane-2-carboxylic acid
[(10r,11s,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-8,17-dioxo-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaen-13-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
[(10r,11s,13r,14r,15s)-3,4,5,11,14,20,21,22-octahydroxy-8,17-dioxo-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaen-13-yl]methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(2r,3r)-3-[(10s,11r)-11-formyl-3,4,5,16,17,18-hexahydroxy-8,13-dioxo-9,12-dioxatricyclo[12.4.0.0²,⁷]octadeca-1(18),2(7),3,5,14,16-hexaen-10-yl]-2,3-dihydroxypropyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(2r,3r)-3-[(10s,11r)-11-formyl-3,4,5,16,17,18-hexahydroxy-8,13-dioxo-9,12-dioxatricyclo[12.4.0.0²,⁷]octadeca-1(18),2(7),3,5,14,16-hexaen-10-yl]-2,3-dihydroxypropyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(10s,11r,12r,13s,15r)-3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(10s,11r,12r,13s,15r)-3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(10s,11r,12r,13s,15s)-3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(10s,11r,12r,13s,15s)-3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
1-o-(e)-caffeoyl-4,6-(s)-hhdp-β-d-glucopy-ranose
NA
{"Ingredient_id": "HBIN002900","Ingredient_name": "1-o-(e)-caffeoyl-4,6-(s)-hhdp-\u03b2-d-glucopy-ranose","Alias": "NA","Ingredient_formula": "C29H24O17","Ingredient_Smile": "C1C2C(C(C(C(O2)OC(=O)C=CC3=CC(=C(C=C3)O)O)O)O)OC(=O)C4=CC(=C(C(=C4C5=C(C(=C(C=C5C(=O)O1)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "2908","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
{3,4,5,11,14,20,21,22-octahydroxy-8,17-dioxo-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaen-13-yl}methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
{3,4,5,11,14,20,21,22-octahydroxy-8,17-dioxo-9,12,16-trioxatetracyclo[16.4.0.0²,⁷.0¹⁰,¹⁵]docosa-1(18),2,4,6,19,21-hexaen-13-yl}methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl 3-(3,4-dihydroxyphenyl)prop-2-enoate
(10s,11s,12r,13s,15r)-3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(10s,11s,12r,13s,15r)-3,4,5,11,12,21,22,23-octahydroxy-8,18-dioxo-9,14,17-trioxatetracyclo[17.4.0.0²,⁷.0¹⁰,¹⁵]tricosa-1(23),2(7),3,5,19,21-hexaen-13-yl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate